BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 17464468)

  • 1. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.
    Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T
    Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease: beta-Amyloid protein and tau.
    Morishima-Kawashima M; Ihara Y
    J Neurosci Res; 2002 Nov; 70(3):392-401. PubMed ID: 12391602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies.
    Iqbal K; Grundke-Iqbal I
    Acta Neuropathol; 2005 Jan; 109(1):25-31. PubMed ID: 15645264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau.
    Hardy J; Duff K; Hardy KG; Perez-Tur J; Hutton M
    Nat Neurosci; 1998 Sep; 1(5):355-8. PubMed ID: 10196523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the neuropathology of familial Alzheimer's disease.
    Shepherd C; McCann H; Halliday GM
    Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F; Kedikian G; Heredia L; Heredia F; Añel AD; Rosa AL; Lorenzo A
    Neurobiol Aging; 2009 Sep; 30(9):1379-92. PubMed ID: 18187234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small non-fibrillar assemblies of amyloid beta-protein bearing the Arctic mutation induce rapid neuritic degeneration.
    Whalen BM; Selkoe DJ; Hartley DM
    Neurobiol Dis; 2005 Nov; 20(2):254-66. PubMed ID: 16242634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T
    J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
    Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
    Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
    Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
    Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's mechanisms in ischemic brain degeneration.
    Pluta R; Ułamek M; Jabłoński M
    Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.